DNA intercalator BMH-21 inhibits RNA polymerase I independent of DNA damage response

DNA intercalation is a major therapeutic modality for cancer therapeutic drugs. The therapeutic activity comes at a cost of normal tissue toxicity and genotoxicity. We have recently described a planar heterocyclic small molecule DNA intercalator, BMH-21, that binds ribosomal DNA and inhibits RNA pol...

Descripción completa

Detalles Bibliográficos
Autores principales: Colis, Laureen, Peltonen, Karita, Sirajuddin, Paul, Liu, Hester, Sanders, Sara, Ernst, Glen, Barrow, James C., Laiho, Marikki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147329/
https://www.ncbi.nlm.nih.gov/pubmed/24952786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147329/
https://www.ncbi.nlm.nih.gov/pubmed/24952786

Ejemplares similares